News Releases

Speakers from remote radiology specialist OpenRad will discuss the launch of its enterprise reporting platform and outline the firm's vision for the future of teleradiology

Radiology residents receive scholarship, research publication in Applied Radiology supplement, and invite to RSNA reception

Bracco’s attendance at RSNA follows FDA approval of Gadopiclenol injection, a novel macrocyclic high-relaxivity gadolinium-based contrast agent which will be commercialized as VUEWAYTM (gadopiclenol) injection by Bracco^{i, ii}

Simplifies health systems ability to develop a comprehensive lung nodule patient surveillance program

VUEWAY injection is highly stable and shows the highest relaxivity among gadolinium-based contrast agents available for clinical useⁱ

This groundbreaking breast imaging technology helps clinicians confidently characterize breast masses, potentially saving patients time, money, and anxiety